Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Other financing activities (2023 - 2025)

Historic Other financing activities for Abivax (ABVX) over the last 2 years, with Q2 2025 value amounting to $56598.0.

  • Abivax's Other financing activities fell 7819.21% to $56598.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $319569.1, marking a year-over-year change of. This contributed to the annual value of $261805.9 for FY2024, which is 4848.34% up from last year.
  • Abivax's Other financing activities amounted to $56598.0 in Q2 2025, which was down 7819.21% from $262971.1 recorded in Q1 2025.
  • In the past 5 years, Abivax's Other financing activities registered a high of $262971.1 during Q1 2025, and its lowest value of $1098.2 during Q3 2024.